Postma R - Search Results

1

Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.

Postma R, Schröder FH, van Leenders GJ, Hoedemaeker RF, Vis AN, Roobol MJ, van der Kwast TH. Postma R, et al. Eur Urol. 2007 Jul;52(1):89-97. doi: 10.1016/j.eururo.2007.01.030. Epub 2007 Jan 16. Eur Urol. 2007. PMID: 17257742 Clinical Trial.

2

Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years.

Postma R, Roobol M, Schröder FH, van der Kwast TH. Postma R, et al. Cancer. 2004 Mar 1;100(5):968-75. doi: 10.1002/cncr.20048. Cancer. 2004. PMID: 14983492 Free article. Clinical Trial.

3

Lesions predictive for prostate cancer in a screened population: first and second screening round findings.

Postma R, Roobol M, Schröder FH, van der Kwast TH. Postma R, et al. Prostate. 2004 Nov 1;61(3):260-6. doi: 10.1002/pros.20105. Prostate. 2004. PMID: 15368469

4

4-year prostate specific antigen progression and diagnosis of prostate cancer in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.

Schröder FH, Raaijmakers R, Postma R, van der Kwast TH, Roobol MJ. Schröder FH, et al. Among authors: postma r. J Urol. 2005 Aug;174(2):489-94; discussion 493-4. doi: 10.1097/01.ju.0000165568.76908.5c. J Urol. 2005. PMID: 16006878

5

Tumour features in the control and screening arm of a randomized trial of prostate cancer.

Postma R, van Leenders AG, Roobol MJ, Schröder FH, van der Kwast TH. Postma R, et al. Eur Urol. 2006 Jul;50(1):70-5. doi: 10.1016/j.eururo.2005.11.005. Epub 2005 Dec 19. Eur Urol. 2006. PMID: 16434136 Clinical Trial.

6

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.

Roemeling S, Roobol MJ, Postma R, Gosselaar C, van der Kwast TH, Bangma CH, Schröder FH. Roemeling S, et al. Among authors: postma r. Eur Urol. 2006 Sep;50(3):475-82. doi: 10.1016/j.eururo.2006.04.019. Epub 2006 May 3. Eur Urol. 2006. PMID: 16713065

7

Gleason score, age and screening: modeling dedifferentiation in prostate cancer.

Draisma G, Postma R, Schröder FH, van der Kwast TH, de Koning HJ. Draisma G, et al. Among authors: postma r. Int J Cancer. 2006 Nov 15;119(10):2366-71. doi: 10.1002/ijc.22158. Int J Cancer. 2006. PMID: 16858675

8

Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.

de Vries SH, Postma R, Raaijmakers R, Roemeling S, Otto S, de Koning HJ, Schröder FH. de Vries SH, et al. Among authors: postma r. Eur Urol. 2007 Feb;51(2):366-74; discussion 374. doi: 10.1016/j.eururo.2006.07.052. Epub 2006 Aug 15. Eur Urol. 2007. PMID: 16930812 Review.

9

hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.

Raaijmakers R, de Vries SH, Blijenberg BG, Wildhagen MF, Postma R, Bangma CH, Darte C, Schröder FH. Raaijmakers R, et al. Among authors: postma r. Eur Urol. 2007 Nov;52(5):1358-64. doi: 10.1016/j.eururo.2007.04.037. Epub 2007 Apr 20. Eur Urol. 2007. PMID: 17499425 Clinical Trial.

10

Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.

Postma R, van Marion R, van Duin M, Vissers KJ, Wink JC, Schröder FH, Tanke HJ, Szuhai K, van der Kwast TH, van Dekken H. Postma R, et al. Anticancer Res. 2006 Mar-Apr;26(2A):1193-200. Anticancer Res. 2006. PMID: 16619524 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters